Open AccessMultiple endocrine neoplasia 2A (MEN 2A) syndrome
Author(s) -
J Breza,
J Breza
Publication year - 2018
Publication title -
bratislavské lekárske listy/bratislava medical journal
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.387
H-Index - 32
eISSN - 1336-0345
pISSN - 0006-9248
DOI - 10.4149/bll_2018_034
Subject(s) - pheochromocytoma , metanephrine , medicine , normetanephrine , multiple endocrine neoplasia , adrenalectomy , multiple endocrine neoplasia type 2 , thyroid , adrenal gland , metanephrines , germline mutation , endocrinology , pathology , urology , gastroenterology , biology , mutation , biochemistry , gene
In the MEN 2A syndrome, which is the most common of the three types of MEN, three endocrine systems are affected simultaneously or subsequently by the development of tumours manifested by medullary thyroid gland carcinoma, pheochromocytoma (often bilateral) and hyperparathyroidism.